WPD Pharmaceuticals Inc. (CSE: WBIO)
Canada
· Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Sep 25, 2024, 9:30 AM EDT
WPD Pharmaceuticals Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 0 | 0.09 | 0.02 | 0.3 | 1.24 | 2.95 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.09 | 0.02 | 0.3 | 1.24 | 2.95 | Upgrade
|
| Cash Growth | -98.62% | 260.85% | -92.10% | -75.69% | -58.02% | 118857.60% | Upgrade
|
| Other Receivables | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 | 0.22 | Upgrade
|
| Receivables | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 | 0.22 | Upgrade
|
| Prepaid Expenses | 0 | 0 | - | 0.06 | 0.03 | 0.01 | Upgrade
|
| Restricted Cash | - | - | - | 1.41 | 0.63 | - | Upgrade
|
| Total Current Assets | 0.05 | 0.12 | 0.08 | 1.8 | 1.94 | 3.18 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.07 | 0.09 | 0.09 | Upgrade
|
| Long-Term Investments | 0.22 | 0.22 | - | - | - | 0.48 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.66 | 0.33 | Upgrade
|
| Total Assets | 0.27 | 0.35 | 0.08 | 1.86 | 2.68 | 4.07 | Upgrade
|
| Accounts Payable | 0.56 | 0.53 | 0.45 | 1.62 | 0.8 | 0.61 | Upgrade
|
| Accrued Expenses | 0.03 | 0.05 | 0.09 | 0.16 | 0.03 | - | Upgrade
|
| Short-Term Debt | - | - | - | 1.03 | 0.09 | 0.19 | Upgrade
|
| Current Portion of Leases | - | - | - | 0.02 | 0.02 | 0.06 | Upgrade
|
| Current Unearned Revenue | - | - | - | 2.43 | 0.63 | - | Upgrade
|
| Other Current Liabilities | 0.02 | 0.02 | 0.02 | 0.67 | - | - | Upgrade
|
| Total Current Liabilities | 0.61 | 0.6 | 0.55 | 5.92 | 1.58 | 0.86 | Upgrade
|
| Long-Term Debt | 0.34 | 0.3 | - | - | - | - | Upgrade
|
| Total Liabilities | 0.95 | 0.9 | 0.55 | 5.92 | 1.58 | 0.86 | Upgrade
|
| Common Stock | 17.14 | 17.08 | 17.08 | 17.08 | 17.08 | 15.83 | Upgrade
|
| Retained Earnings | -22.19 | -22.01 | -21.93 | -25.79 | -20.17 | -12.64 | Upgrade
|
| Comprensive Income & Other | 4.37 | 4.37 | 4.37 | 4.65 | 4.19 | 0.02 | Upgrade
|
| Shareholders' Equity | -0.68 | -0.56 | -0.48 | -4.06 | 1.11 | 3.21 | Upgrade
|
| Total Liabilities & Equity | 0.27 | 0.35 | 0.08 | 1.86 | 2.68 | 4.07 | Upgrade
|
| Total Debt | 0.34 | 0.3 | - | 1.04 | 0.12 | 0.25 | Upgrade
|
| Net Cash (Debt) | -0.34 | -0.22 | 0.02 | -0.74 | 1.12 | 2.7 | Upgrade
|
| Net Cash Growth | - | - | - | - | -58.34% | - | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | 0.00 | -0.01 | 0.01 | 0.79 | Upgrade
|
| Filing Date Shares Outstanding | 115.99 | 113.44 | 113.44 | 113.44 | 113.44 | 113.44 | Upgrade
|
| Total Common Shares Outstanding | 114.82 | 113.44 | 113.44 | 113.44 | 113.44 | 111.52 | Upgrade
|
| Working Capital | -0.56 | -0.48 | -0.48 | -4.12 | 0.36 | 2.32 | Upgrade
|
| Book Value Per Share | -0.01 | -0.00 | -0.00 | -0.04 | 0.01 | 0.03 | Upgrade
|
| Tangible Book Value | -0.68 | -0.56 | -0.48 | -4.06 | 0.45 | 2.88 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.00 | -0.00 | -0.04 | 0.00 | 0.03 | Upgrade
|
| Machinery | - | - | - | 0.1 | 0.1 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.